Luftibus in the School: a Study on the Respiratory Health of Schoolchildren. (LUIS)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03659838 |
|
Recruitment Status :
Completed
First Posted : September 6, 2018
Last Update Posted : September 6, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
This study assessed the respiratory health of schoolchildren from the canton of Zurich by combining self-reported information on respiratory symptoms with lung function test results and air pollution measurements.
Luftibus in the school (LUIS) is a population-based study conducted in the canton of Zurich, Switzerland. Between the years 2013 and 2016 a bus with equipment for lung function testing and air pollution measurement visited numerous schools across the canton Zurich. The parents of the schoolchildren filled in a questionnaire with validated questions on upper and lower respiratory symptoms, trigger factors, diagnosis, treatment of respiratory symptoms, health behavior and environmental factors. The children were interviewed using a shorter questionnaire. Fieldworkers measured lung function (spirometry and double tracer gas single-breath washout) and an airway inflammation test (fractional exhaled nitric oxide) in the bus. The recruited population included 3500 schoolchildren aged 6 to 16 years from the canton of Zurich.
Respiratory symptoms and their influence on physical activity and sleep have a strong impact on children's quality of life and school performance. The results of this study will provide new insights on schoolchildren's respiratory health that may help to establish new recommendations and influence policy makers' decisions.
| Condition or disease |
|---|
| Respiratory Disease |
Background:
Few population-based studies have recently investigated the epidemiology of childhood respiratory symptoms in Switzerland.
Objectives:
The Luftibus in the school study was setup to assess the respiratory health of schoolchildren from the canton of Zurich and to investigate relationships between respiratory symptoms, lung function and air pollution.
Methods:
Recruitment and participation:
All schools in the canton of Zürich were invited to participate in the LUIS study. Those schools interested in participating were approached. The eligible study population were children aged 6 to 16 years with parental consent from the schools that agreed to participate. Prior to each school visit, parents received a letter with information about the project, an informed consent form and a questionnaire. During the school visit, trained field workers performed lung function tests in children at the school, interviewed the children using a short questionnaire and collected the parental questionnaires. A subsample of the schools was visited again one year after the first visit in order to collect follow-up information, using the same procedure and gathering the same measurements.
Information collected:
- Parental questionnaire: Frequency, duration, severity, triggers of upper and lower respiratory symptoms, previous doctor diagnosis of asthma, use of medication, health behaviors, environmental factors, household characteristics and family history.
- Children's questionnaire: Respiratory symptoms, asthma diagnosis, medication and smoking.
- Anthropometric data: Height and weight were measured by fieldworkers in the schools in a standardized way.
- Complementary tests: Spirometry, fractional exhaled nitric oxide (FeNO) and double tracer gas single-breath washout (SBW) were performed in the school by trained fieldworkers according to ATS criteria.
- Air pollution measurements: Air pollution detectors placed on the roof of the bus measured nitrogen dioxide (NO2), inhalable particles of 10 micrometers or less in diameter (PM10) and ozone concentration at the school site.
Study database:
The study questionnaire database was created using Epidata, which allows data entry and data extraction in CVS format.
Funding:
Lung League of Zurich
| Study Type : | Observational |
| Actual Enrollment : | 3500 participants |
| Observational Model: | Other |
| Time Perspective: | Cross-Sectional |
| Official Title: | Luftibus in the School: a Population-based Study of Respiratory Symptoms, Lung Function and Air Pollution. |
| Actual Study Start Date : | November 28, 2013 |
| Actual Primary Completion Date : | December 15, 2016 |
| Actual Study Completion Date : | December 15, 2016 |
| Group/Cohort |
|---|
|
Participants
Schoolchildren from the canton of Zürich aged 6 to 16 years
|
- Parent-reported respiratory symptoms [ Time Frame: At baseline ]Prevalence of upper and lower respiratory tract symptoms including wheeze, cough, rhinitis and snoring, reported using parent questionnaires.
- Self-reported respiratory symptoms [ Time Frame: At baseline ]Prevalence of upper and lower respiratory tract symptoms including wheeze, cough, rhinitis and snoring, reported using participant questionnaires.
- Lung function measurements: Spirometry, forced expiratory volume in 1 second z-scores [ Time Frame: At baseline ]Forced expiratory volume in 1 second (FEV1) z-scores calculated based on Global Lung Function Initiative (GLI) reference values.
- Lung function measurements: Spirometry, forced vital capacity z-scores [ Time Frame: At baseline ]Forced vital capacity (FVC) z-scores calculated based on Global Lung Function Initiative (GLI) reference values.
- Lung function measurements: Single-breath washout [ Time Frame: At baseline ]Slope from the tidal (alveolar) phase III (SIII) from double-tracer gas single-breath washout test curves.
- Airway inflammation [ Time Frame: At baseline ]Airway inflammation measured by levels of fractional concentration of exhaled nitric oxide.
- Parent-reported respiratory symptoms [ Time Frame: One year after baseline ]Prevalence of upper and lower respiratory tract symptoms including wheeze, cough, rhinitis and snoring, reported using parent questionnaires.
- Self-reported respiratory symptoms [ Time Frame: One year after baseline ]Prevalence of upper and lower respiratory tract symptoms including wheeze, cough, rhinitis and snoring, reported using participant questionnaires.
- Lung function measurements: Spirometry, forced expiratory volume in 1 second z-scores [ Time Frame: One year after baseline ]Forced expiratory volume in 1 second (FEV1) z-scores calculated based on Global Lung Function Initiative (GLI) reference values.
- Lung function measurements: Spirometry, forced vital capacity z-scores [ Time Frame: One year after baseline ]Forced vital capacity (FVC) z-scores calculated based on Global Lung Function Initiative (GLI) reference values.
- Lung function measurements: Single-breath washout [ Time Frame: One year after baseline ]Slope from the tidal (alveolar) phase III (SIII) from double-tracer gas single-breath washout test curves.
- Airway inflammation [ Time Frame: One year after baseline ]Airway inflammation measured by levels of fractional concentration of exhaled nitric oxide.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 6 Years to 16 Years (Child) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
| Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Schoolchildren living in the canton of Zürich
- Age range 6 to 16 years
- Parental consent to participate
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03659838
| Switzerland | |
| University Children's Hospital Zürich | |
| Zürich, Switzerland, 8032 | |
| Principal Investigator: | Alexander Möller, PD Dr.med | University Children's Hospital, Zurich |
| Responsible Party: | University Children's Hospital, Zurich |
| ClinicalTrials.gov Identifier: | NCT03659838 |
| Other Study ID Numbers: |
LUIS |
| First Posted: | September 6, 2018 Key Record Dates |
| Last Update Posted: | September 6, 2018 |
| Last Verified: | August 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Yes |
| Plan Description: | Researchers wanting to use the Luftibus in the school dataset can contact the study team and propose a research topic. A concept sheet describing the planned analyses and publication must be approved by the Luftibus in the school study team. For further details, contact: Alexander.Moeller@kispi.uzh.ch Claudia.Kuehni@ispm.unibe.ch |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
Asthma Wheeze Cough |
Snoring Bronchial obstruction Air pollution |
|
Respiration Disorders Respiratory Tract Diseases |

